SCHEMBL18718041

SCHEMBL18718041

CCCC(C)(C)Cc1cccc(C(=O)Nc2cccc3ccccc23)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.56
▸ RAB9A P51151 3/20 0.56
▸ CYP1A2 P05177 2/20 0.56
▸ CYP3A4 P08684 2/20 0.56
▸ CYP2D6 P10635 2/20 0.56
▸ CYP2C19 P33261 2/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ LMNA P02545 1/20 0.54
▸ ALDH1A1 P00352 4/20 0.49
▸ HPGD P15428 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ MMP8 P22894 1/20 0.49
▸ KMT2A Q03164 4/20 0.48
▸ PTGES O14684 1/20 0.47
▸ EPHX1 P07099 1/20 0.47
▸ ALOX5 P09917 1/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ TRPV1 Q8NER1 1/20 0.46
▸ GAA P10253 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1690511 0.88 NPC1 (0.61) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL1696487 0.84 NPC1 (0.62) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL15676743 0.84 NPC1 (0.66) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL18718185 0.77 MEN1 (0.63) RAB9ALMNAALDH1A1MAPTKDM4E
SCHEMBL18773847 0.77 KMT2A (0.77) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL1690488 0.75 GAA (0.60) NPC1RAB9ACYP1A2CYP3A4CYP2C19
SCHEMBL10397739 0.74 NPC1 (0.71) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL30184438 0.73 NPC1 (1.00) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL4642544 0.73 NPC1 (1.00) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL21914836 0.73 NPC1 (0.80) NPC1RAB9ACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9617224-B2 Five-membered heterocycles useful as serine protease inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-04-11 — — US disclosed
Send feedback